Durlin E. Hickok

Biography

 Dr. Hickok is the former senior vice president and chief medical officer of ProteoGenix, Inc., a company focused on developing diagnostics for pregnancy and neonatal management.  Prior to joining ProteoGenix, he served as senior vice president at Adeza Biomedical and part of the management team that successfully developed the fetal fibronectin test for prediction of preterm birth, which was acquired by Cytyc Corporation in 2007. Dr. Hickok has authored more than 80 publications on topics including preterm delivery, preeclampsia, and other aspects of pregnancy care and testing. Dr. Hickok’s residency and fellowship training were at the University of Washington, Department of Obstetrics and Gynecology. He also received a masters degree in Public Health through the Robert Wood Johnson Clinical Scholars Program.

Research Interest

Gynecology